iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Richmond Brothers Inc.

Richmond Brothers Inc. decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 11.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,290 shares of the financial services provider’s stock after selling 959 shares during the quarter. iShares Biotechnology ETF comprises approximately 2.0% of Richmond Brothers Inc.’s holdings, making the stock its 9th largest position. Richmond Brothers Inc.’s holdings in iShares Biotechnology ETF were worth $1,001,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of IBB. Kingsview Wealth Management LLC lifted its holdings in shares of iShares Biotechnology ETF by 7.6% in the fourth quarter. Kingsview Wealth Management LLC now owns 3,139 shares of the financial services provider’s stock valued at $426,000 after buying an additional 221 shares during the period. Gladstone Institutional Advisory LLC raised its position in shares of iShares Biotechnology ETF by 7.1% during the fourth quarter. Gladstone Institutional Advisory LLC now owns 6,316 shares of the financial services provider’s stock worth $858,000 after purchasing an additional 420 shares during the period. Corient Private Wealth LLC raised its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after purchasing an additional 841 shares during the period. Nemes Rush Group LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $322,000. Finally, Weil Company Inc. acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $310,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of iShares Biotechnology ETF stock opened at $147.52 on Thursday. The stock’s fifty day moving average is $145.63 and its 200-day moving average is $138.47. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.